98 ATA3271: an armored, next-generation off-the-shelf, allogeneic, mesothelin-CAR T cell therapy for solid tumors

• Alfonso Brito,
• Yannick Bulliard,
• Jiangyue Liu,
• Xianhui Chen,
• Jason Karlen,
• Tiffany Jheng,
• Philippe Foubert,
• Janani Krishnamurthy,
• Blake Aftab

Affiliations

Alfonso Brito

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Yannick Bulliard

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Jiangyue Liu

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Xianhui Chen

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Jason Karlen

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Tiffany Jheng

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Philippe Foubert

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Janani Krishnamurthy

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA

Blake Aftab

Atara Biotherapeutics, Inc., Thousand Oaks, CA, USA